Literature DB >> 806263

BL-P1654, ticarcillin, and carbenicillin: in vitro comparison alone and in combination with gentamicin against Pseudomonas aeruginosa.

E R Wald, H C Standiford, B A Tatem, F M Calia, R B Hornick.   

Abstract

Minimum inhibitory concentrations of carbenicillin, ticarcillin, and BL-P1654 were determined for 89 clinical isolates of Pseudomonas aeruginosa. Ticarcillin was generally twice as active and BL-P1654 eight to 16 times as active as carbenicillin. Usually carbenicillin and ticarcillin killed at the same concentration or twice the concentration needed to inhibit, whereas 400 mug of BL-P1654 per ml was not bactericidal for the majority of isolates tested. The inhibitory effect of all three drugs varied markedly with the size of bacterial inoculum. When therapeutically achievable concentrations were used, adding gentamicin enhanced the inhibitory and bactericidal activity of all three penicillin derivatives for the majority of isolates. However, inhibition of isolates highly resistant to gentamicin was not improved by combining the semisynthetic penicillins with gentamicin.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 806263      PMCID: PMC429136          DOI: 10.1128/AAC.7.3.336

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  11 in total

1.  The hemostatic defect produced by carbenicillin.

Authors:  C H Brown; E A Natelson; W Bradshaw; T W Williams; C P Alfrey
Journal:  N Engl J Med       Date:  1974-08-08       Impact factor: 91.245

2.  Resistance of Pseudomonas aeruginosa to carbenicillin.

Authors:  S M Bell; D D Smith
Journal:  Lancet       Date:  1969-04-12       Impact factor: 79.321

3.  Carbenicillin and hypokalemia.

Authors:  J Klastersky; B Vanderklen; D Daneau; M Mathiew
Journal:  Ann Intern Med       Date:  1973-05       Impact factor: 25.391

4.  The importance of underlying disease in patients with gram-negative bacteremia.

Authors:  M A Freid; K L Vosti
Journal:  Arch Intern Med       Date:  1968-05

5.  Simplified, accurate method for antibiotic assay of clinical specimens.

Authors:  J V Bennett; J L Brodie; E J Benner; W M Kirby
Journal:  Appl Microbiol       Date:  1966-03

Review 6.  Infections due to gram-negative organisms: an analysis of 860 patients with bacteremia at the University of Minnesota Medical Center, 1958-1966.

Authors:  H L DuPont; W W Spink
Journal:  Medicine (Baltimore)       Date:  1969-07       Impact factor: 1.889

7.  Carbenicillin: a clinical and laboratory evaluation.

Authors:  M I Marks; T C Eickhoff
Journal:  Ann Intern Med       Date:  1970-08       Impact factor: 25.391

8.  -carboxy-3-thienylmethylpenicillin (BRL 2288), a new semisynthetic penicillin: in vitro evaluation.

Authors:  R Sutherland; J Burnett; G N Rolinson
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1970

9.  Comparative activity of tobramycin, amikacin, and gentamicin alone and with carbenicillin against Pseudomonas aeruginosa.

Authors:  R M Kluge; H C Standiford; B Tatem; V M Young; W H Greene; S C Schimpff; F M Calia; R B Hornick
Journal:  Antimicrob Agents Chemother       Date:  1974-10       Impact factor: 5.191

10.  In vitro studies of alpha-carboxyl-3-thienylmethyl penicillin, a new semisynthetic penicillin.

Authors:  G P Bodey; B Deerhake
Journal:  Appl Microbiol       Date:  1971-01
View more
  18 in total

1.  Activities of daptomycin and vancomycin alone and in combination with rifampin and gentamicin against biofilm-forming methicillin-resistant Staphylococcus aureus isolates in an experimental model of endocarditis.

Authors:  Kerry L LaPlante; Suzanne Woodmansee
Journal:  Antimicrob Agents Chemother       Date:  2009-06-29       Impact factor: 5.191

Review 2.  Antibiotic combinations: should they be tested?

Authors:  G M Eliopoulos; C T Eliopoulos
Journal:  Clin Microbiol Rev       Date:  1988-04       Impact factor: 26.132

3.  Laboratory studies with a new broad-spectrum penicillin, pirbenicillin.

Authors:  J A Retsema; A R English; J E Lynch
Journal:  Antimicrob Agents Chemother       Date:  1976-06       Impact factor: 5.191

4.  Synergistic activity of aminoglycoside-beta-lactam combinations against Pseudomonas aeruginosa with an unusual aminoglycoside antibiogram.

Authors:  R B Clark; C B Pakiz; M K Hostetter
Journal:  Med Microbiol Immunol       Date:  1990       Impact factor: 3.402

Review 5.  [Fifty years of penicillins. A review of structure-effect relationships of beta-lactamase antibiotics and their microbiological and clinical relevance (author's transl)].

Authors:  A Dalhoff
Journal:  Infection       Date:  1979       Impact factor: 3.553

Review 6.  Role of aminoglycoside antibiotics in the treatment of intra-abdominal infection.

Authors:  J L Ho; M Barza
Journal:  Antimicrob Agents Chemother       Date:  1987-04       Impact factor: 5.191

7.  Comparative in vitro evaluation of the effects of ticarcillin and carbenicillin upon Psuedomonas aeruginosa.

Authors:  E Kalkani; N Marketos
Journal:  Antimicrob Agents Chemother       Date:  1976-01       Impact factor: 5.191

8.  In vitro activity of gentamicin, amikacin and netilmicin alone and in combination with carbenicillin against Serratia marcescens.

Authors:  S M Pogwizd; S A Lerner
Journal:  Antimicrob Agents Chemother       Date:  1976-12       Impact factor: 5.191

9.  Ticarcillin in combination with cephalothin or gentamicin as empiric antibiotic therapy in granulocytopenic cancer patients.

Authors:  S C Schimpff; S Landesman; D M Hahn; H C Standiford; C L Fortner; V M Young; P H Wiernik
Journal:  Antimicrob Agents Chemother       Date:  1976-11       Impact factor: 5.191

10.  Comparative activity in vitro of ticarcillin, BL-P1654, and carbenicillin.

Authors:  T C Eickhoff; J M Ehret
Journal:  Antimicrob Agents Chemother       Date:  1976-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.